Amphista and BMS partner to develop protein degradation therapies
Amphista Therapeutics, a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics, today announced a strategic collaboration with...
Catalent Acquires Commercial-Scale Cell Therapy Development and Manufacturing Facility in Princeton, New Jersey, from Erytech
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across...
Pluristyx and Accelerated Biosciences announce availability of clinical-grade immune-privileged human trophoblast stem cells
Pluristyx, Inc., an advanced therapy tools and services biotechnology company, and Accelerated Biosciences, a regenerative medicine innovator in the use of proprietary human trophoblast...
Tweaks In Booster Pitch By Moderna Before Fall Approaches
The question is whether to boost or not to boost. The answer is a resounding yes, as per officials at mRNA expert Moderna. Moderna's...
FDA Expects COVID Vaccines To Become An Annual Occurrence
According to a trio of prominent US Food and Drug Administration experts, the US may need to update its COVID-19 vaccines every year, and...
Despite Global Issues, Indian Pharma Exports Remain Strong
The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in 2021-22, with a phenomenal increase of about $10 billion...
Newer Omicron Types Initiate Their Own Coronavirus Waves
The data is undeniable: COVID-19 instances and hospitalizations are on the rise in the United States, despite patchy documentation. Most states are witnessing an upsurge,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...